GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

about

Treatment strategies for women with polycystic ovary syndrome.

P2860

Q52859456-B931685C-1953-4414-8BC2-2A9049C3852E

P2860

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

Item

http://www.wikidata.org/entity/Q39170244

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@en

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@nl

type

Item

label

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@en

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@nl

prefLabel

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@en

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@nl

P1476

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

@en

P2093

Elizabeth Mary Lamos

http://www.w3.org/2001/XMLSchema#string

Rana Malek

http://www.w3.org/2001/XMLSchema#string

Stephen N Davis

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction

Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome.

Letrozole versus clomiphene for infertility in the polycystic ovary syndrome.

Treatment of hirsutism and acne in hyperandrogenism.

Metformin versus acarbose therapy in patients with polycystic ovary syndrome (PCOS): a prospective randomised double-blind study.

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

Metabolic actions of insulin in men and women

Insulin enhances ACTH-stimulated androgen and glucocorticoid metabolism in hyperandrogenic women.

Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

The prevalence and features of the polycystic ovary syndrome in an unselected population.

P304

401-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/17512433.2017.1292125

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28276778

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

about

P2860

P2860

GLP-1 receptor agonists in the treatment of polycystic ovary syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921